Modular Domains of Host Proteins Regulate Filovirus Maturation
Modular Domains of Host Proteins Regulate Filovirus Maturation
批准号:
9517218
负责人:
RONALD N HARTY
金额:
$24.64万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-15 至 2019-12-31
关键词:
AffectAntiviral AgentsAutophagocytosisBAG3 geneBindingBinding ProteinsBiologicalCategoriesCell SurvivalCell membraneCellsDataDefense MechanismsDisease ProgressionEbola virusEnsureExcisionFilamentFiloviridae InfectionsFilovirusFrankfurt-Marburg Syndrome VirusFunding MechanismsGenetic EngineeringGoalsHomoHost DefenseHost Defense MechanismInnate Immune ResponseLaboratoriesMammalian CellMediatingMolecular ChaperonesN-terminalPathway interactionsPlayProcessProteinsPublishingRoleSiteStressTestingTherapeutic AgentsTimeUbiquitinationVaccinesVesicular stomatitis Indiana virusViralViral ProteinsVirionVirusVirus AssemblyVirus-like particlebaseimaging approachinnovationinsightmutantnew therapeutic targetnovelnovel therapeutic interventionpathogenpreventproteostasisrecombinant virusrecruittransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ultimate goal of this proposal is to elucidate the novel antiviral mechanism of host BAG3; a newly
discovered filovirus VP40 interacting protein that inhibits viral egress. Filoviruses (Ebola [EBOV] and
Marburg [MARV]) are Category A, high-priority pathogens, for which there are no commercially available
vaccines or therapeutic agents. Thus, exploratory and innovative approaches are warranted to better
understand viral-host interactions that both promote and inhibit the transmission of these deadly viruses.
Our laboratory focuses on the mechanisms by which filoviruses interact with and recruit host proteins to
regulate the budding process. Here, we identified an unanticipated interaction between filovirus VP40 and
the host protein BAG3. BAG3 is a stress-regulated, co-chaperone protein whose function is to ensure cell
survival and protein homeostasis via Chaperone-Assisted Selective Autophagy (CASA). While BAG3 has
been shown to positively influence entry and replication for some viruses, we found that the interaction of
the PPxY motif of both EBOV and MARV VP40 with the single N-terminal WW-domain of BAG3 leads to an
unexpected decrease in egress of both EBOV and MARV VP40 virus-like particles (VLPs), as well as VSV
recombinant viruses that serve as functional EBOV surrogates, as they are genetically engineered to
express either EBOV VP40 WT or mutant L-domains in place of the L-domain of VSV M. We hypothesize
that BAG3 expression is induced following filovirus infection, and that BAG3 targets VP40 for removal
and/or sequestration from the site of budding at the plasma membrane. We will use a rigorous multifaceted
approach to interrogate the mechanisms by which BAG3 disrupts virus particle egress, thus providing new
insight into the potential role of CASA as a novel and specific host defense strategy to counteract the ability
of VP40 to promote efficient egress and spread of virus particles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Host Filamin Proteins in Regulating Filovirus Entry and Egress
-
批准号:10644499
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2023
-
负责人:RONALD N HARTY
-
依托单位:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
-
批准号:10688262
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2022
-
负责人:RONALD N HARTY
-
依托单位:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
-
批准号:10545109
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2022
-
负责人:RONALD N HARTY
-
依托单位:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
-
批准号:10380684
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2021
-
负责人:RONALD N HARTY
-
依托单位:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
-
批准号:10217843
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2021
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10257889
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10368115
-
项目类别:
-
资助金额:$101.54万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10599837
-
项目类别:
-
资助金额:$101.29万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSES
-
批准号:8903846
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Regulation of Intracellular Pathways Involved in Filovirus Budding
-
批准号:8635498
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8853616
-
项目类别:
-
资助金额:$46.66万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8490299
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8389432
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:9088302
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Defenses Against Filoviruses.
-
批准号:8076883
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2010
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Defenses Against Filoviruses.
-
批准号:7964676
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2010
-
负责人:RONALD N HARTY
-
依托单位:
Packaging of Ebola Virus RNA into Budding VLPs
-
批准号:7339650
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
Role of ISG15 in Inhibition of Ebola Virus Budding
-
批准号:7927824
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
Role of ISG15 in Inhibition of Ebola Virus Budding
-
批准号:7391373
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
Packaging of Ebola Virus RNA into Budding VLPs
-
批准号:7176652
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
海外基金